Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Homo sapiens | vitamin D (1,25- dihydroxyvitamin D3) receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | 4'-phosphopantetheinyl transferase ffp | 224 aa | 186 aa | 26.3 % | |
Trichomonas vaginalis | conserved hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 197 aa | 22.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Brugia malayi | steroid hormone receptor | vitamin D (1,25- dihydroxyvitamin D3) receptor | 427 aa | 416 aa | 24.5 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Entamoeba histolytica | hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 198 aa | 28.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | carboxylesterase 5A | 0.0973 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0028 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0973 | 1 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0028 | 0 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.1441 | 0.0733 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0028 | 0 | 0.5 |
Onchocerca volvulus | 0.0164 | 0.1441 | 1 | |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0164 | 0.1441 | 0.0733 |
Onchocerca volvulus | 0.0164 | 0.1441 | 1 | |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0164 | 0.1441 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Mycobacterium leprae | conserved hypothetical protein | 0.0028 | 0 | 0.5 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0028 | 0 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0973 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0164 | 0.1441 | 1 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Schistosoma mansoni | acetylcholinesterase | 0.0164 | 0.1441 | 0.0733 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Echinococcus granulosus | acetylcholinesterase | 0.0973 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0164 | 0.1441 | 1 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0164 | 0.1441 | 0.0733 |
Brugia malayi | Carboxylesterase family protein | 0.0973 | 1 | 1 |
Onchocerca volvulus | 0.0164 | 0.1441 | 1 | |
Echinococcus multilocularis | acetylcholinesterase | 0.0973 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0973 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0164 | 0.1441 | 0.0733 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0973 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0 | 0.5 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0028 | 0 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.1441 | 0.0733 |
Echinococcus granulosus | neuroligin | 0.0164 | 0.1441 | 0.0733 |
Echinococcus multilocularis | acetylcholinesterase | 0.0973 | 1 | 1 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0164 | 0.1441 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0164 | 0.1441 | 0.0733 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.1441 | 0.0733 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0973 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0164 | 0.1441 | 1 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0164 | 0.1441 | 0.0733 |
Schistosoma mansoni | gliotactin | 0.0164 | 0.1441 | 0.0733 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0164 | 0.1441 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0028 | 0 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0164 | 0.1441 | 0.0733 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Onchocerca volvulus | 0.0164 | 0.1441 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Onchocerca volvulus | 0.0164 | 0.1441 | 1 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0028 | 0 | 0.5 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.1441 | 0.0733 |
Echinococcus multilocularis | neuroligin | 0.0164 | 0.1441 | 0.0733 |
Brugia malayi | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Echinococcus granulosus | carboxylesterase 5A | 0.0973 | 1 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0164 | 0.1441 | 0.0733 |
Loa Loa (eye worm) | carboxylesterase | 0.0973 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.1441 | 0.0733 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.